314 EXPERIMENTAL INFECTION OF ANOPHELES DARLINGI MOSQUITOES BY PLASMODIUM VIVAX FROM NATURALLY INFECTED PATIENTS IN THE PERUVIAN AMAZON. (1st January 2006)
- Record Type:
- Journal Article
- Title:
- 314 EXPERIMENTAL INFECTION OF ANOPHELES DARLINGI MOSQUITOES BY PLASMODIUM VIVAX FROM NATURALLY INFECTED PATIENTS IN THE PERUVIAN AMAZON. (1st January 2006)
- Main Title:
- 314 EXPERIMENTAL INFECTION OF ANOPHELES DARLINGI MOSQUITOES BY PLASMODIUM VIVAX FROM NATURALLY INFECTED PATIENTS IN THE PERUVIAN AMAZON.
- Authors:
- Bharti, A. R.
Chuquiyauri, R.
Segura, E.
Lopez, V.
Stancil, J.
Llanos, A.
Vinetz, J. M. - Abstract:
- Abstract : Purpose of Study: In Peru, the incidence of malaria has increased dramatically since the early 1990s and Plasmodium vivax remains the predominant species. Although P. vivax does not cause life-threatening disease, it is still a considerable source of morbidity but has been widely understudied. This study was conducted to determine the transmission patterns of P. vivax from naturally infected patients in the Peruvian Amazon to Anopheles darlingi mosquitoes. Methods: The study was conducted over a period of 14 months from May 2004 to June 2005 and included symptomatic patients with P. vivax malaria from Iquitos, Peru. The widely used artificial membrane feeding method was used to infect mosquitoes. Mosquito midguts were dissected after a week and oocysts were counted by microscopic examination. Summary of Results: A total of 102 patients with symptomatic P. vivax infection were enrolled in the study. Approximately 50% (50/102) of the patients were febrile, with a temperature of 37.7°C or more. Pallor was noted in 64.7% (66/102) patients. Gametocytemia ranged from 0-106 with a mean of 20.61. A total of 4, 017 mosquitoes successfully fed on the blood using the artificial membrane feeding technique, with 2, 631 (65%) surviving until the time of midgut dissection. Approximately 50% (52/102) of the patient specimens infected mosquitoes and 23% (602/2, 631) of the mosquitoes had at least one reported oocyst. The mean oocyst load per infected midgut was 21.1 with a rangeAbstract : Purpose of Study: In Peru, the incidence of malaria has increased dramatically since the early 1990s and Plasmodium vivax remains the predominant species. Although P. vivax does not cause life-threatening disease, it is still a considerable source of morbidity but has been widely understudied. This study was conducted to determine the transmission patterns of P. vivax from naturally infected patients in the Peruvian Amazon to Anopheles darlingi mosquitoes. Methods: The study was conducted over a period of 14 months from May 2004 to June 2005 and included symptomatic patients with P. vivax malaria from Iquitos, Peru. The widely used artificial membrane feeding method was used to infect mosquitoes. Mosquito midguts were dissected after a week and oocysts were counted by microscopic examination. Summary of Results: A total of 102 patients with symptomatic P. vivax infection were enrolled in the study. Approximately 50% (50/102) of the patients were febrile, with a temperature of 37.7°C or more. Pallor was noted in 64.7% (66/102) patients. Gametocytemia ranged from 0-106 with a mean of 20.61. A total of 4, 017 mosquitoes successfully fed on the blood using the artificial membrane feeding technique, with 2, 631 (65%) surviving until the time of midgut dissection. Approximately 50% (52/102) of the patient specimens infected mosquitoes and 23% (602/2, 631) of the mosquitoes had at least one reported oocyst. The mean oocyst load per infected midgut was 21.1 with a range of 0-395. Conclusions: This is the first study of its kind conducted in the Peruvian Amazon. There were 2 important observations: (1) only half of the patients were able to infect mosquitoes and (2) there was substantial variation in the transmission of infection to mosquitoes as measured by oocyst loads and percentage mosquitoes infected. Determining factors that affect transmission (eg, anemia, gametocyte count and maturity, fever, anti-inflammatory medications, antigametocyte antibodies) will help identify alternative interventions that can be used in addition to the current control measures. Patients who are more efficient transmitters can then be targeted first for these interventional methods. … (more)
- Is Part Of:
- Journal of investigative medicine. Volume 54:Number 1(2006)
- Journal:
- Journal of investigative medicine
- Issue:
- Volume 54:Number 1(2006)
- Issue Display:
- Volume 54, Issue 1 (2006)
- Year:
- 2006
- Volume:
- 54
- Issue:
- 1
- Issue Sort Value:
- 2006-0054-0001-0000
- Page Start:
- S134
- Page End:
- S134
- Publication Date:
- 2006-01-01
- Subjects:
- Clinical medicine -- Periodicals
Medicine -- Research -- Periodicals
Medicine
Research -- United States
Clinical medicine
Medicine -- Research
Periodicals
616.075 - Journal URLs:
- http://journals.lww.com/jinvestigativemed/pages/default.aspx ↗
http://jim.bmj.com/ ↗
https://journals.sagepub.com/home/IMJ ↗
http://journals.lww.com ↗ - DOI:
- 10.2310/6650.2005.X0004.313 ↗
- Languages:
- English
- ISSNs:
- 1081-5589
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5008.010000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18032.xml